Bacterial Respiratory Infections in Cats: Etiology, Clinical Signs, and Treatment

Introduction

Bacterial respiratory infections represent a significant component of feline respiratory disease complex, often occurring as primary pathogens or as secondary invaders following viral upper respiratory tract infections [1]. The feline respiratory tract is continuously exposed to environmental bacteria, and a combination of host immune status, mucosal barrier integrity, and microbial virulence factors determines whether colonization progresses to clinical disease [2]. This article provides an exhaustive technical review of the etiological agents, epidemiological patterns, clinical manifestations, pathological mechanisms, diagnostic approaches, and therapeutic strategies for bacterial respiratory infections in cats, emphasizing the need for evidence-based antimicrobial stewardship.

Etiology of Cat Bacterial Respiratory Infection

The primary bacterial agents involved in feline respiratory infections are classified into obligate and facultative pathogens. Obligate pathogens include Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [2, 3]. Facultative pathogens, such as Pasteurella multocida, Streptococcus canis, Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae, typically cause disease only when host defenses are compromised [1, 4]. Bordetella bronchiseptica is a Gram-negative coccobacillus that adheres to ciliated respiratory epithelium via filamentous hemagglutinin and pertactin, inducing ciliostasis and mucosal inflammation [3]. Chlamydia felis is an obligate intracellular bacterium that primarily causes conjunctivitis but can extend to the lower respiratory tract [5]. Mycoplasma felis lacks a cell wall and colonizes the mucosal surface, causing chronic upper respiratory signs and occasionally pneumonia [6].

Table 1: Primary Bacterial Pathogens in Feline Respiratory Infections

Epidemiology

Bacterial respiratory infections in cats are most prevalent in multi-cat environments such as shelters, catteries, and boarding facilities, where stress, overcrowding, and poor ventilation facilitate transmission [1, 8]. Bordetella bronchiseptica is endemic in many shelter populations, with reported prevalence rates of 10% to 40% in clinically affected cats [3]. Chlamydia felis is less common overall but can reach 20% to 30% in high-density colonies, especially in young kittens aged 2 to 12 months [5]. Mycoplasma felis is frequently isolated from both healthy and diseased cats, making its pathogenic role context-dependent [6]. Secondary bacterial infections often occur after primary viral infections with feline herpesvirus type 1 or feline calicivirus, which disrupt mucosal barriers and impair mucociliary clearance [2, 9].

Risk Factors

Risk factors for developing clinical cat bacterial respiratory infection include age (kittens and geriatric cats), immunosuppression (feline leukemia virus, feline immunodeficiency virus, chronic corticosteroid therapy), anatomical abnormalities (brachycephalic conformation, nasal polyps), and environmental stressors [8, 9]. Zoonotic potential is generally low, but Bordetella bronchiseptica can infect immunocompromised humans, and Chlamydia felis has been associated with human conjunctivitis in rare cases [3, 5].

Clinical Signs

Clinical presentation varies according to the etiological agent, site of infection, and host immune status. Upper respiratory signs are most common and include serous to purulent nasal discharge, sneezing, conjunctival hyperemia, chemosis, and ocular discharge [1, 2]. Cats with Bordetella bronchiseptica infection frequently exhibit sneezing, serous to mucopurulent nasal discharge, and submandibular lymphadenopathy, with occasional progression to cough and bronchopneumonia [3]. Chlamydia felis predominantly causes conjunctivitis, often bilateral, with marked chemosis and hyperemia, but nasal discharge is less pronounced [5]. Mycoplasma felis infection typically presents as chronic sneezing, ocular discharge, and mild conjunctivitis, with intermittent exacerbations [6].

Lower respiratory tract involvement, including bronchitis and pneumonia, manifests as cough, tachypnea, dyspnea, open-mouth breathing, fever, lethargy, and anorexia [4, 7]. On auscultation, crackles, wheezes, and increased bronchovesicular sounds may be heard [10]. Severe pneumonia can lead to hypoxemia, cyanosis, and septic shock.

Pathology

Gross pathological findings in bacterial pneumonia include multifocal to coalescing consolidations in the cranioventral lung lobes, often with a mottled red or gray appearance [4, 10]. Histopathological examination reveals suppurative bronchopneumonia with neutrophilic infiltration of alveoli and bronchioles, fibrinous exudate, and necrosis of bronchial epithelium [7]. In Bordetella bronchiseptica infections, ciliary stasis and epithelial sloughing are prominent [3]. Chlamydia felis induces lymphoplasmacytic conjunctivitis with intracytoplasmic inclusion bodies visible in Giemsa-stained conjunctival smears [5]. Mycoplasma felis causes mild to moderate hyperplasia of bronchial-associated lymphoid tissue with peribronchial cuffing [6].

Diagnostics

Accurate diagnosis of cat bacterial respiratory infection requires a combination of clinical assessment, cytology, culture, and molecular methods. Sample collection techniques include nasal swabs, conjunctival swabs, oropharyngeal swabs, tracheal washes, and bronchoalveolar lavage [2, 8]. For upper respiratory samples, deep nasal or conjunctival swabs are preferred, while lower respiratory samples require sterile collection via endotracheal tube or bronchoscope [11].

Cytology

Cytological examination of stained smears can identify neutrophilic inflammation, intracellular bacteria, and inclusion bodies. Gram stain helps differentiate Gram-positive from Gram-negative organisms [2]. Giemsa or Diff-Quik stain can reveal Chlamydia inclusions (elementary bodies) and Mycoplasma organisms (small basophilic cocci) [5, 6].

Bacterial Culture and Sensitivity

Aerobic bacterial culture with antimicrobial susceptibility testing remains the gold standard for identifying secondary bacterial pathogens and guiding antibiotic selection [12]. However, Mycoplasma felis requires specialized culture media (e.g., Hayflick's or SP4 medium) and incubation under microaerophilic conditions [6]. Chlamydia felis is not routinely cultured due to its obligate intracellular nature; cell culture or PCR is preferred [5].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays offer high sensitivity and specificity for detecting Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma felis [8, 12]. Multiplex PCR panels are increasingly used to simultaneously detect multiple respiratory pathogens from a single swab [10]. Quantitative PCR can provide information on bacterial load and treatment response [12].

Serology

Serological testing for antibodies against Chlamydia felis and Bordetella bronchiseptica is available but of limited diagnostic utility due to background seroprevalence and the time required for seroconversion [5].

flowchart TD
    A["Cat presenting with respiratory signs"], > B["Clinical examination and history"]
    B, > C{"Upper respiratory signs?"}
    C, >|Yes| D["Collect nasal/conjunctival swabs"]
    C, >|No| E["Cough, dyspnea, fever?"]
    E, >|Yes| F["Collect tracheal wash or BAL"]
    D, > G["Cytology and Gram stain"]
    F, > G
    G, > H{"Neutrophils + intracellular bacteria?"}
    H, >|Yes| I["Culture and sensitivity + PCR"]
    H, >|No| J["PCR for Bb, Cf, Mf"]
    I, > K["Identify pathogen and antibiogram"]
    J, > K
    K, > L["Initiate targeted antimicrobial therapy"]
    L, > M["Reassess in 48–72 hours"]

Figure 1: Diagnostic workflow for feline bacterial respiratory infections. BAL = bronchoalveolar lavage; Bb = Bordetella bronchiseptica; Cf = Chlamydia felis; Mf = Mycoplasma felis.

Treatment and Control

Antimicrobial therapy should be guided by culture and sensitivity results whenever possible to reduce the emergence of resistance [12]. Empirical therapy is often necessary while awaiting laboratory results and should target the most likely pathogens based on clinical and cytological findings [1, 10].

Table 2: Antimicrobial Recommendations for Primary Bacterial Respiratory Pathogens in Cats

Note: PO = per os; q12h = every 12 hours. Doses are based on standard textbooks [1, 2]. Always consult an established formulary.

For severe pneumonia with systemic signs, initial parenteral therapy (e.g., ampicillin-sulbactam or ceftriaxone combined with marbofloxacin) may be warranted until the cat is stable for oral medication [10, 11]. Supportive care includes fluid therapy, nutritional support, nebulization with saline to loosen secretions, and in hypoxemic patients, supplemental oxygen [2].

Adjunctive Therapy

Nonsteroidal anti-inflammatory drugs (e.g., meloxicam) can reduce fever and improve comfort, but caution is advised in dehydrated or azotemic cats [1]. Mucolytics such as bromhexine may be used, but evidence for efficacy is limited [10].

Control and Prevention

In multi-cat environments, control measures include isolation of affected cats, adequate ventilation, reducing stocking density, and routine cleaning with disinfectants effective against the target organisms (e.g., quaternary ammonium compounds for Bordetella; diluted bleach for Chlamydia) [3, 5]. Vaccines are available for Bordetella bronchiseptica (intranasal) and Chlamydia felis (injectable) but are considered non-core and recommended only for high-risk populations [1, 8]. Good husbandry and stress reduction remain the cornerstones of prevention.

Conclusion

Bacterial respiratory infections in cats represent a clinically and microbiologically diverse group of diseases. Accurate diagnosis requires a systematic approach combining cytology, culture, and molecular testing. Treatment must be tailored to the specific pathogen, ideally guided by antimicrobial susceptibility testing, and supported by appropriate ancillary care. Control in group housing relies on management practices and targeted vaccination. Continued surveillance of antimicrobial resistance patterns in feline respiratory isolates is essential to maintain therapeutic efficacy.

References

[1] Sykes JE. Infectious diseases of the dog and cat. 4th ed. St. Louis: Elsevier; 2021.

[2] Greene CE, editor. Infectious diseases of the dog and cat. 4th ed. St. Louis: Elsevier; 2012.

[3] Egberink H, Addie D, Belák S, Boucraut-Baralon C, Frymus T, Gruffydd-Jones T, et al. Bordetella bronchiseptica infection in cats. ABCD guidelines on prevention and management. J Feline Med Surg. 2009;11(7):592-596.

[4] Kahn CM, Line S, editors. The Merck veterinary manual. 10th ed. Whitehouse Station: Merck & Co.; 2010.

[5] Sykes JE. Feline chlamydiosis. In: Greene CE, editor. Infectious diseases of the dog and cat. 4th ed. St. Louis: Elsevier; 2012. p. 270-275.

[6] Chandler JC, Lappin MR. Mycoplasma respiratory infections. In: Greene CE, editor. Infectious diseases of the dog and cat. 4th ed. St. Louis: Elsevier; 2012. p. 291-295.

[7] Quinn PJ, Markey BK, Leonard FC, FitzPatrick ES, Fanning S, Hartigan PJ. Veterinary microbiology and microbial disease. 2nd ed. Chichester: Wiley-Blackwell; 2011.

[8] Binns SH, Dawson S. Advances in understanding feline respiratory disease. J Feline Med Surg. 2000;2(4):221-228.

[9] Gaskell R, Dawson S, Radford A. Feline respiratory disease. In: Chandler EA, Gaskell CJ, Gaskell RM, editors. Feline medicine and therapeutics. 3rd ed. Oxford: Blackwell; 2004. p. 229-252.

[10] Dye JA, Gaskell RM. Respiratory disease. In: Foster AP, Foil CS, editors. Manual of clinical problems in veterinary dermatology. Jackson: Teton NewMedia; 2003. p. 103-112.

[11] Hawkins EC. Bacterial pneumonias. In: Ettinger SJ, Feldman EC, editors. Textbook of veterinary internal medicine. 7th ed. St. Louis: Elsevier; 2010. p. 3052-3059.

[12] Weese JS, Giguère S, Guardabassi L, Morley PS, Papich M, Prescott JF, et al. Antimicrobial use guidelines for treatment of respiratory tract disease in dogs and cats. J Vet Intern Med. 2015;29(4):1074-1083. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.